Well now we know why data was slow to be released for Cohort 3. Very happy to wait until ASCO THE premier oncology conference worldwide.
Good to get some more shares a lot cheaper than expected. Now we sit back and let this astute management team do what they do best.
Great to hear Jenn talking about her roles in 4 of the 6 approved Car-T therapies to remind us what we are here for.
Ann: CHM 1101 GBM Abstract Accepted for ASCO 2023 Presentation, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $28.14K | 7.037M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 243067 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 14771167 | 22 |
View Market Depth
| Last trade - 15.39pm 20/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |